Muscle relaxation monitoring device, muscle relaxation monitoring program, and recording medium

The muscle relaxation monitoring device addresses electrode installation problems by identifying causes through electrical signal analysis, facilitating rapid response and efficient surgical processes.

JP7948891B2Active Publication Date: 2026-11-11NIHON KOHDEN CORP
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
JP2023084124
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2023-05-22
Publication Date
2026-11-11
Estimated Expiration
2043-05-22

AI Technical Summary

Technical Problem

Electromyography-based muscle relaxation monitoring devices face installation issues such as electrode detachment or improper placement during surgical preparation or surgery, leading to time-consuming problem resolution.

Method used

A muscle relaxation monitoring device with a stimulation output unit, signal detection unit, and cause determination unit that identifies the cause of electrode abnormalities based on electrical signals, enabling rapid response to installation issues.

Benefits of technology

Enables quick identification and resolution of installation abnormalities, allowing for efficient surgical preparation and surgery by determining the cause of electrode issues.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007948891000001
    Figure 0007948891000001
  • Figure 0007948891000002
    Figure 0007948891000002
  • Figure 0007948891000003
    Figure 0007948891000003
Patent Text Reader

Abstract

To provide a muscle relaxation monitoring device, a muscle relaxation monitoring program, and a recording medium that allow an abnormality to be coped with quickly and allow preparations for surgery, etc. to be carried out quickly by specifying a cause for an abnormality of the muscle relaxation monitoring device at the time of preparations for surgery, etc.SOLUTION: A muscle relaxation monitoring device includes: a stimulation output unit for stimulating nerves through a stimulation electrode attached to a living body; and a signal detection unit for detecting a biological signal generated from a muscle in reaction to the stimulation to nerves by the stimulation output unit as an electric signal through a derivation electrode stuck to the living body. Nerves are stimulated by the stimulation output unit, and a cause for an installation abnormality is determined by the electric signal detected by the signal detection unit.SELECTED DRAWING: Figure 8
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present invention relates to a muscle relaxation monitoring device, a muscle relaxation monitoring program, and a recording medium. BACKGROUND ART

[0002] Anesthesia is generally used when performing surgery on a patient. Even when the patient has no consciousness or sensation due to anesthesia, muscle contraction may occur due to reflexes or the like. For this reason, during major surgeries, muscle relaxants are administered to the patient to keep the patient still and facilitate the surgery. Surgical preparations such as administering an anesthetic are performed before the start of surgery, and muscle relaxants are also administered at this time. After administering the muscle relaxant, the muscle relaxation state is monitored to confirm that the patient has entered a muscle relaxation state. In addition, since the effect of the muscle relaxant decreases over time, the muscle relaxation state is monitored and the muscle relaxant is re-administered according to the progress of the surgery. As devices for monitoring the muscle relaxation state, muscle relaxation monitoring devices that stimulate a patient's nerve and measure muscle contraction caused by the stimulation, such as those disclosed in Patent Documents 1 and 2, are used. Patent Document 1 discloses a muscle relaxation monitoring device that measures movement caused by muscle contraction due to nerve stimulation using acceleration.

[0003] On the other hand, Patent Document 2 discloses an electromyography-type muscle relaxation monitoring device that electrically stimulates a nerve and measures a biological signal generated in a muscle as a reaction thereto. In this muscle relaxation monitoring device, two stimulation electrodes are attached near the nerve, and two lead-out electrodes are attached near the muscle that contracts via the nerve. Then, a stimulation current is passed from the stimulation output unit through the stimulation electrodes to stimulate the nerve, and the biological signal generated in the muscle at that time is detected by the signal detection unit as an electrical signal obtained through the lead-out electrodes.

[0004] The electromyography-type muscle relaxation monitoring device passes a stimulation current, acquires an electromyogram which is a biological reaction, and monitors the muscle relaxation state. As a basic usage, the current value of the stimulation current is set before administering the muscle relaxant, and the current value of the stimulation current is adjusted. PRIOR ART DOCUMENTS PATENT DOCUMENTS

[0005] [Patent Document 1] Japanese Patent Publication No. 2006-326050 [Patent Document 2] Japanese Patent Publication No. 2021-69724 [Overview of the Initiative] [Problems that the invention aims to solve]

[0006] Electromyography-based muscle relaxation monitoring devices can experience installation problems such as electrode detachment or improper placement during surgical preparation or surgery. These installation problems can stem from various factors, requiring a comprehensive approach to address them. Therefore, preparing the device and recovering from installation problems can sometimes be time-consuming.

[0007] One embodiment of the present invention aims to enable rapid response to abnormalities in a muscle relaxation monitoring device during surgical preparation, etc., by making it possible to identify the cause of the abnormality, thereby enabling prompt action to be taken, and thus allowing surgical preparation to be carried out quickly. [Means for solving the problem]

[0008] A muscle relaxation monitoring device according to one embodiment of the present invention is characterized by comprising: a stimulation output unit that stimulates nerves via stimulation electrodes attached to the body of a subject; a signal detection unit that detects as an electrical signal the biological signal generated from the muscle in response to the stimulation of the nerve by the stimulation output unit via an output electrode attached to the body; and a cause determination unit that determines the cause of an abnormal installation of the output electrode based on the electrical signal detected by the signal detection unit after stimulating the nerve by the stimulation output unit. [Effects of the Invention]

[0009] This invention enables rapid response to abnormalities in the installation of muscle relaxation monitoring devices during surgical preparation or surgery by identifying the cause. As a result, surgical preparation and surgery can be performed more quickly. [Brief explanation of the drawing]

[0010] [Figure 1] A diagram showing the configuration of a muscle relaxation monitoring system equipped with a muscle relaxation monitoring device in an embodiment. [Figure 2] In this embodiment, an electromyogram of a living organism that has not been administered a muscle relaxant. [Figure 3] In this embodiment, electromyography is obtained by the TOF method from a living organism that has not been administered a muscle relaxant. [Figure 4] In one embodiment, an electromyogram obtained by the TOF method when the muscle relaxant is acting incompletely. [Figure 5] First abnormal waveform in the embodiment. [Figure 6] Second abnormal waveform in the embodiment. [Figure 7] Third abnormal waveform in the embodiment. [Figure 8] A flowchart for determining and displaying the cause of an installation abnormality when setting the current value of the stimulation current in the embodiment. [Modes for carrying out the invention]

[0011] Figure 1 shows the configuration of a muscle relaxation monitoring system in an embodiment attached to the upper limb L of a patient subject. The muscle relaxation monitoring system includes a muscle relaxation monitoring device 1, a display device 2, a speaker 3, a stimulating electrode 41, wiring 42, an output electrode 51, a signal line 52, a grounding electrode 61, and a grounding wire 62. A pair of stimulating electrodes 41 and wiring 42 is provided, and a pair of output electrodes 51 and signal line 52 is also provided. The display device 2 and speaker 3 may be incorporated into the muscle relaxation monitoring device 1.

[0012] The muscle relaxation monitoring device 1 comprises a control unit 11, a storage unit 12, a stimulation output unit 13, a signal detection unit 14, a display output unit 15, an audio output unit 16, and an operation unit 17. The control unit 11 is composed of a CPU. The display output unit 15 and the audio output unit 16 are notification output units for notifying the results of muscle relaxation monitoring, but they also function as notification output units for notifying abnormalities in stimulation current, causes of installation abnormalities, and corresponding actions taken in response to the causes of installation abnormalities.

[0013] The memory unit 12, stimulation output unit 13, signal detection unit 14, display output unit 15, audio output unit 16, and operation unit 17 are connected to the control unit 11. The stimulation output unit 13 is connected to a pair of stimulation electrodes 41 via a pair of wires 42, and the signal detection unit 14 is connected to a pair of output electrodes 51 via a pair of signal lines 52. Furthermore, the signal detection unit 14 is connected to a ground electrode 61 via a ground wire 62. The stimulation electrodes 41, output electrodes 51, and ground electrode 61 are surface electrodes that are attached to the human body. The display output unit 15 of the muscle relaxation monitoring device 1 is connected to the display device 2, and the audio output unit 16 is connected to the speaker 3.

[0014] Figure 1 shows the upper limb L of the subject, in which the ulnar nerve extends into the arm. The ulnar nerve is the nerve that causes contraction of muscles such as the adductor pollicis and abductor digiti minimi in the hand. When using the muscle relaxation monitoring device 1, the stimulating electrode 41, the output electrode 51, and the ground electrode 61 are attached to the body. The pair of stimulating electrodes 41 are attached to the position corresponding to the ulnar nerve, and the pair of output electrodes 51 are attached to the position corresponding to the abductor digiti minimi muscle and its nearby tendon. In addition, the ground electrode 61 is attached between the stimulating electrode 41 and the output electrode 51.

[0015] The signal detection unit 14 detects the potential difference between two biosignals generated in the abductor digiti minimi muscle and tendon, which are input via the signal line 52. A pair of stimulating electrodes 41 are attached along the ulnar nerve, and the stimulation output unit 13 stimulates the ulnar nerve by sending a pulsed stimulating current through the wiring 42 and the stimulating electrodes 41. In this embodiment, the duration for which the stimulating current is applied is 0.2 msec. The signal detection unit 14 then detects the biosignals generated from the muscles in response to the stimulation of the ulnar nerve as electrical signals between the pair of output electrodes 51. The signal detection unit 14 has a differential amplifier and amplifies the potential difference between the pair of output electrodes 51. The signal detection unit 14 then performs A / D conversion on the amplified voltage value and sends it to the control unit 11. The ground electrode 61 suppresses the influence of noise voltage transmitted from the subject's body through the upper limb L on the detected potential via the output electrodes 51. Noise voltage is mainly generated by voltage pulses caused by stimulating currents, or by the propagation of these voltage pulses through the subject's body.

[0016] The derived data detected by the signal detection unit 14 and A / D-converted is input to the control unit 11, and the muscle relaxation state is monitored. The monitoring result is displayed on the display device 2 via the display output unit 15, and is audibly notified from the speaker 3 via the audio output unit 16.

[0017] Further, the muscle relaxation monitoring device 1 performs adjustment of the stimulation current value and the like by switch operation of the operation unit 17. The control unit 11 and the storage unit 12 also function as a stimulation current value setting unit that adjusts the stimulation current and sets the stimulation current value in the preparation stage of surgery. Furthermore, the control unit 11 and the storage unit 12 also function as a cause determination unit that determines the cause of an installation abnormality of the lead electrodes 51 and the like based on the electrical signal detected by the signal detection unit 14.

[0018] As described above, in the muscle relaxation monitoring system, as shown in FIG. 1, the muscle relaxation monitoring device 1 is connected to the upper limb L of the subject, and a stimulation current is passed from the stimulation output unit 13. Then, the biological signal generated in the muscle is detected as an electrical signal by the signal detection unit 14 to obtain an electromyogram. The stimulation current from the stimulation output unit 13 flows between the two stimulation electrodes 41 to stimulate the ulnar nerve, and the biological signal generated in the muscle connected to the ulnar nerve is detected by the signal detection unit 14 as an electrical signal of the voltage between the two lead electrodes 51. The biological signal changes depending on the muscle relaxation state caused by the action of the muscle relaxant.

[0019] FIG. 2 shows an example of an electromyogram of a living body to which no muscle relaxant is administered. The electromyogram shows the potential difference of the electrical signal obtained from the two lead electrodes 51 attached to the upper limb L of the subject. The vertical axis represents the potential difference, and the horizontal axis represents time. In order to avoid the appearance of direct noise caused by the stimulation current in the figure, the electromyogram in FIG. 2 shows the potential difference between the two lead electrodes 51 immediately after the pulse of the stimulation current of 0.2 msec ends. The electromyogram in FIG. 2 shows a non-administration waveform E of a living body to which no muscle relaxant is administered.

[0020] The non-administered waveform E shown in Figure 2 starts with a negative potential due to the residual voltage from the stimulating current, reaches a positive peak potential PPe of 6mV at around 6msec, then a negative peak potential NPe of -4mV at around 11msec, and finally converges to a potential of 0mV at around 20msec. In Figure 2, the biosignal period Tp, which is the period during which a biosignal is generated in the muscle due to the stimulating current to the nerve, is 0 to approximately 20msec. The non-administered waveform E will have a shape similar to that shown in Figure 2, although the voltage value and timing of the peak potential may vary slightly depending on the electrode placement and the characteristics of the body.

[0021] On the other hand, when a muscle relaxant is administered, no biosignal is generated at the highest degree of muscle relaxation, and the electrical potential becomes 0, with no positive peak potential PPe or negative peak potential NPe. Furthermore, while biosignals are generated as the degree of muscle relaxation decreases, the biosignal for each stimulus when multiple stimuli are applied in a short period of time gradually decreases. Utilizing this, the muscle relaxation monitoring device 1 of this embodiment can monitor the degree of muscle relaxation using the TOF (Train of Four) method. Note that the muscle relaxation monitoring device 1 can obtain electromyograms from various stimuli, not just the TOF method.

[0022] Figure 3 shows an electromyogram representing the biosignals when stimulated using the TOF method before administration of a muscle relaxant. In this embodiment, the degree of muscle relaxation is calculated using the TOF method. In the TOF method of this embodiment, four consecutive stimuli at 500 msec intervals are treated as one group, and one group is repeated every 15 seconds. The duration of the stimulating current is 0.2 msec. Stimulation is performed by passing a stimulating current from the stimulating output unit 13 between the stimulating electrodes 41 shown in Figure 1. Figure 3 shows four electromyographic waveforms W1 to W4 that are sequentially generated by four consecutive stimuli. The vertical axis represents the voltage value V, and the horizontal axis represents time t.

[0023] Note that the biosignal period Tp, which is the time interval during which the potential of electromyographic waveforms W1 to W4 fluctuates, is small compared to the stimulation interval of 500 msec. Therefore, for convenience, the electromyographic waveforms W1 to W4 in Figure 3 are displayed with the stimulation timing compressed and the starting point slightly shifted in the positive direction of time t. The value of time t in Figure 3 indicates the time of electromyographic waveform W1 corresponding to the first stimulation. The starting point W1S of electromyographic waveform W1 is 0 msec. The starting point W2S of electromyographic waveform W2 is at a time position of 500 msec in the t direction, but is compressed in the -t direction and shown as in Figure 3. The same applies to electromyographic waveforms W3 and W4, with the starting points W3S and W4S being at time positions of 1000 msec and 1500 msec, respectively. Also, to avoid noise due to the stimulation current, as in Figure 2, electromyographic waveforms W1 to W4 show the potential difference from immediately after the pulse of the stimulation current ends.

[0024] Before administration of the muscle relaxant, the electromyographic waveforms W1-W4 have the shape of the non-administration waveform E shown in Figure 2, and the biosignal period Tp in electromyographic waveforms W1-W4 is the same length. Figure 3 shows only the biosignal period Tp of electromyographic waveform W1. As shown in Figure 3, the amplitudes f1-f4, which are the difference between the highest and lowest potentials during the biosignal period Tp in electromyographic waveforms W1-W4, are the same magnitude. Before administration of the muscle relaxant, the amplitude of the electromyographic waveform does not decrease while applying the stimulating current of group 1.

[0025] In the TOF method, the ratio of the amplitude f1 of the electromyographic waveform W1 resulting from the first stimulus to the amplitude f4 of the electromyographic waveform W4 resulting from the fourth stimulus (TOF ratio) is expressed as a percentage and used as an indicator of muscle relaxation. Amplitudes f1 and f4 are the voltage values ​​of the difference between the highest and lowest potentials during the biosignal period Tp in electromyographic waveforms W1 and W4, respectively. When the muscle relaxant has no effect, the TOF ratio is 100%. In Figure 3, which is an electromyographic image before administration of the muscle relaxant, f1=f4 and the TOF ratio is 100%.

[0026] When a muscle relaxant is administered and the degree of muscle relaxation reaches its maximum, the electromyographic waveforms W1 to W4 all become 0mV (not shown in the diagram). Furthermore, the amplitudes f1 to f4 also all become 0mV. In this state, even if the nerve is stimulated by the stimulating current, no biological signal is generated in the muscle, and the potential difference between the pair of lead electrodes 51 is 0mV.

[0027] On the other hand, at a degree of muscle relaxation where the effect of the muscle relaxant is weak, such as when time has passed since the administration of a muscle relaxant, the amplitude f of the electromyographic waveform decreases with each increase in the number of stimulations within a group of stimuli. Figure 4 shows the electromyogram representing the biosignal when stimulation is performed using the TOF method at this time. In Figure 4, four consecutive stimulations at 500 msec intervals are considered as one group, and one group is repeated every 15 seconds. The duration of the stimulation current is 0.2 msec. Stimulation is performed by passing a stimulation current between the stimulation electrodes 41 shown in Figure 1.

[0028] Figure 4 shows four electromyographic waveforms W1 to W4, which are generated sequentially by four consecutive stimuli. The vertical axis represents the voltage value V, and the horizontal axis represents time t. The biosignal duration Tp for electromyographic waveforms W1 to W4 is the same length. Figure 4 shows only the biosignal duration Tp for electromyographic waveform W1. Since the biosignal duration Tp for electromyographic waveforms W1 to W4 is small compared to the 500 msec interval between stimuli, the timing of the stimuli has been conveniently shortened in Figure 4, and the starting point has been shifted slightly in the positive direction of time t. The numerical value of time t in Figure 4 indicates the time of electromyographic waveform W1 corresponding to the first stimuli. Also, as in Figures 2 and 3, electromyographic waveforms W1 to W4 show the potential difference from immediately after the pulse of the stimulating current has ended. In Figure 4, for electromyographic waveforms W2 to W4, only amplitudes f1 and f4 are listed, and amplitudes f2 and f3 are omitted.

[0029] At a degree of muscle relaxation where the effect of the muscle relaxant is weak, as shown in Figure 4, the amplitude f1 of the electromyogram waveform W1 is the difference between the highest and lowest potentials during the biosignal period Tp in which the electromyogram is generated. The biosignal period Tp shown in Figure 4 is shown in relation to the electromyogram waveform W1. Similarly, the amplitudes f2 to f4 in the electromyogram waveforms W2 to W4 also represent the difference between the highest and lowest potentials during the period in which the electromyogram is generated. In the electromyogram waveforms W1 to W4 at a degree of muscle relaxation where the effect of the muscle relaxant is weak, as shown in Figure 4, the amplitudes f1 to f4 are f1 > f2 > f3 > f4, and gradually decrease.

[0030] In the degree of muscle relaxation shown in Figure 4, where the effect of the muscle relaxant is weak, the TOF ratio = f4 / f1 is slightly less than 50%. Since a TOF ratio > 70% is considered to indicate recovery from muscle relaxation, the electromyogram state in Figure 4 indicates that the muscle is in the process of recovering from muscle relaxation, and has not yet recovered. Note that in Figure 4, the electromyographic waveform W1 is the same as the untreated waveform E, but the amplitude f1 of electromyographic waveform W1 may be smaller than the amplitude fe of the untreated waveform E. However, even if the amplitude f1 is smaller, the amplitude f4 is smaller even more, so the TOF ratio can be used as an indicator of the degree of muscle relaxation.

[0031] The TOF ratio is monitored during surgery to help determine whether to re-administer muscle relaxants. For example, if the TOF ratio exceeds 40%, a decision may be made to re-administer muscle relaxants. In addition, during the preparation phase for surgery, the TOF ratio can be used to confirm whether the patient is in a relaxed state suitable for surgery. While a TOF ratio > 70% is generally considered to indicate recovery from muscle relaxation, in recent years, 80% or 90% are sometimes used as the benchmark.

[0032] <Usage of Muscle Relaxation Monitoring Device 1> Next, the usage of the muscle relaxation monitoring device 1 in the embodiment will be described. First, in the preparation stage for surgery, as shown in Figure 1, a pair of stimulating electrodes 41, a pair of output electrodes 51, and a ground electrode 61 are attached to the subject's upper limb L. Then, before administering the muscle relaxant, the current value of the stimulating current of the muscle relaxation monitoring device 1 is set.

[0033] When the stimulation current value setting switch is turned on in the operation unit 17, the muscle relaxation monitoring device 1 sets the stimulation current value. In this embodiment, the cause of the installation abnormality is determined when the stimulation current value setting unit sets the stimulation current value. During the stimulation current value setting, the stimulation current value is gradually increased and automatically adjusted to an appropriate value. When an electromyogram is measured using the TOF method with the muscle relaxation monitoring device 1 after adjustment, the result is as shown in Figure 3, and the TOF ratio is 100%.

[0034] After the current value of the stimulation current is set, the subject is administered a muscle relaxant. The muscle relaxant gradually induces a state of muscle relaxation in the subject. In a state of complete muscle relaxation, the electromyogram voltage is 0mV. After administration of the muscle relaxant, the electromyogram obtained by TOF during the process of achieving complete muscle relaxation shows, as in Figure 4, that the amplitudes f1 to f4 of the electromyogram waveforms W1 to W4 gradually decrease. Electromyogram waveforms W1 to W4 are the waveforms of the electromyogram generated sequentially by the stimulation current at 500msec intervals.

[0035] During the process of achieving complete muscle relaxation, the amplitude of the electromyographic waveforms W1-W4 decreases with slower intervals of continuous stimulation, as shown in Figure 4, due to the action of the muscle relaxant. In Figure 4, the TOF ratio is less than 70%, indicating that the patient is in a relaxed state. As the action of the muscle relaxant progresses further, the electromyographic waveforms W1-W4 become almost 0mV, and the amplitudes f1-f4 of the electromyographic waveforms W1-W4 also become almost 0mV, resulting in a complete muscle relaxation state. After confirming that sufficient muscle relaxation has been achieved using the muscle relaxation monitoring device 1, the surgery is initiated.

[0036] As time passes after the administration of the muscle relaxant and its effects weaken, the potential changes in the electromyographic waveforms W1 to W4 reappear, as shown in Figure 4. When the TOF ratio exceeds a certain value, a decision is made on whether or not to administer the muscle relaxant again, depending on the progress of the surgery.

[0037] As described above, the muscle relaxation monitoring device 1 performs stimulation and detection procedures using the TOF method. The stimulation procedure involves stimulating nerves via stimulation electrodes 41 attached to the body by the stimulation output unit 13. The detection procedure involves detecting the biological signals generated from the muscles in response to the nerve stimulation by the stimulation output unit 13 as electrical signals via output electrodes 51 attached to the body by the signal detection unit 14. The control of the stimulation and detection procedures is performed by processing in the control unit 11 according to a program stored in the memory unit 12.

[0038] <Determining the cause of installation abnormalities> Even when the stimulation current value setting switch is turned on during the preparation phase for surgery, the muscle relaxation monitoring device 1 performs stimulation and detection procedures, similar to those performed during muscle relaxation monitoring. The stimulation procedure involves stimulating nerves via stimulation electrodes 41 attached to the body using the stimulation output unit 13. The detection procedure involves detecting the biological signals generated from the muscles in response to the nerve stimulation by the stimulation output unit 13 as electrical signals via output electrodes 51 attached to the body using the signal detection unit 14. The control of the stimulation and detection procedures is performed by processing in the control unit 11 according to a program stored in the memory unit 12.

[0039] If, during the preparation phase for surgery, an abnormal waveform is obtained instead of the electromyogram shown in Figure 2 after performing the stimulation and detection procedures to set the stimulation current, it is likely due to an installation error of the muscle relaxation monitoring device 1. Similarly, if an abnormal waveform is obtained during surgery, it is likely due to an installation error of the muscle relaxation monitoring device 1. The abnormal waveform can take on multiple shapes. The muscle relaxation monitoring device 1 performs a determination procedure to determine the cause of the installation error based on the electrical signal detected by the stimulation output unit 13 and the electrical signal detected by the signal detection unit 14. The control of the determination procedure is also performed by processing in the control unit 11 according to a program stored in the memory unit 12.

[0040] (1st abnormal waveform A1) Figure 5 shows the electrical signal of the first abnormal waveform A1 detected by the signal detection unit 14 after nerve stimulation by the stimulation output unit 13, with a solid line. The dotted line represents the non-administered waveform E, shown in Figure 2, which is an electromyogram of a living organism without administration of a muscle relaxant. The first abnormal waveform A1 has a smaller positive peak potential PPa1 and a smaller negative peak potential NPa1 during the biological signal period Tp than the non-administered waveform E. Furthermore, an amplitude fa1, which is the difference between the highest and lowest potentials during the period in which the electromyogram is generated, exists, but it is smaller than the amplitude fe of the non-administered waveform E.

[0041] An electromyogram (EMG) waveform like the first abnormal waveform A1 occurs when there is insufficient stimulation to the nerve. Also, if the two lead electrodes 51 are too close together, it becomes difficult to capture the potential difference due to the biological signal, resulting in the first abnormal waveform A1. Thus, if the difference between the highest and lowest potentials during the period in which the EMG is generated after nerve stimulation by the stimulation output unit 13 is within a predetermined voltage range that is smaller than that of a normal EMG, the muscle relaxation monitoring device 1 determines that it is the first abnormal waveform A1. Determining it as the first abnormal waveform A1 means that there are two possible causes: insufficient nerve stimulation and abnormal proximity of the two lead electrodes 51.

[0042] In the muscle relaxation monitoring device 1 of this embodiment, the first abnormal waveform A1 is determined when the amplitude fa1, which is the difference between the positive peak potential PPa1 and the negative peak potential NPa1, is 0.2 mV or greater (first reference value SV11) and 1.0 mV or less (second reference value SV12). The range between the first reference value SV11 and the second reference value SV12 corresponds to a predetermined voltage range that is smaller than that of a normal electromyogram. The second reference value SV12 is set to a value smaller than the amplitude fe of the non-administered waveform E. Preferably, the second reference value SV12 is a value of 1 / 2 or less of the amplitude fe of the non-administered waveform E. Furthermore, the first reference value SV11 is set to a magnitude that allows the positive peak potential PPa1 and the negative peak potential NPa1 to be recognized.

[0043] During the current value setting process for the stimulation current, the current value is gradually increased and the stimulation current is applied multiple times, but an upper limit is set for the stimulation current value. Then, it is determined whether the electromyogram for the stimulation current at the upper limit value is the first abnormal waveform A1. The determination that it is the first abnormal waveform A1 based on the output of the signal detection unit 14 indicates that the cause of the abnormal placement is due to insufficient nerve stimulation, the two lead electrodes 51 being attached too close together, or the attachment position being off-center from the tendon or muscle.

[0044] The result of the assessment, which is the cause of the installation abnormality, is output from the display output unit 15 and displayed on the display device 2. The display device 2 displays "Insufficient nerve stimulation or abnormal proximity of the attachment position of the lead-out electrode." When the display is shown, an audio signal is output from the audio output unit 16 and a "beep" sound is emitted from the speaker 3 to warn the user.

[0045] Furthermore, the display when a diagnosis is made may also be a display that informs the user of the appropriate action to take depending on the cause of the installation abnormality. In this case, for example, the display may say, "Please ensure that the stimulation electrode is securely attached. If the abnormality persists, move the lead electrode away from the device and reattach it."

[0046] Furthermore, if the first abnormal waveform A1 is obtained during muscle relaxation monitoring in surgery, the amplitude may be reduced due to the effect of muscle relaxants. Therefore, even if the first abnormal waveform A1 is obtained, it should not be determined that it is caused by insufficient nerve stimulation or the like.

[0047] (2nd abnormal waveform A2) Figure 6 shows the electrical signal of the second abnormal waveform A2 detected by the signal detection unit 14 after nerve stimulation by the stimulation output unit 13, with a solid line. The dotted line is the non-administered waveform E, shown in Figure 2, of an electromyogram of a living organism that has not been administered a muscle relaxant. The second abnormal waveform A2 is a distorted waveform of the non-administered waveform E, and the absolute value of the initial voltage of the electromyogram is abnormally large. The electromyogram in Figure 6 also shows the change in the electromyogram from the end of the stimulation current.

[0048] Electromyograms like the second abnormal waveform A2 shown by the solid line in Figure 6 are thought to be caused by residual stimulation artifact noise after the end of the stimulation current generated by the stimulation current. The presence of the ground electrode 61 suppresses the influence of stimulation artifact noise on the electrical signal detected by the signal detection unit 14. However, if the ground electrode 61 is detached, the residual stimulation artifact noise is not suppressed, resulting in an electromyogram like the second abnormal waveform A2. Also, if the stimulation electrode 41 and the output electrode 51 are too close together, the influence of residual stimulation artifact noise becomes large, resulting in the second abnormal waveform A2.

[0049] Stimulation artifact noise significantly affects the electrical signal detected by the signal detection unit 14 during a predetermined period after the end of the stimulation current. If the electrical signal is distorted during a predetermined period after nerve stimulation by the stimulation output unit 13, it is determined to be a second abnormal waveform A2. Determining that it is a second abnormal waveform A2 means that the cause of the installation abnormality is determined to be either that the stimulation electrode 41 and the output electrode 51 are too close together, or that the ground electrode 61 has detached.

[0050] In the muscle relaxation monitoring device 1 of this embodiment, as shown in Figure 6, if the absolute value of the average voltage in the first period Tp1, which is the initial period of the electromyogram, is 20 mV or more, and the absolute value of the average voltage in the second period Tp2 is 10 mV or less, it is determined to be a second abnormal waveform A2. The first period Tp1 is 1 to 2 msec from the end of the stimulation current, and the second period Tp2 is 5 to 10 msec. In this way, by determining the absolute value of the average voltage in the first period Tp1 and the second period Tp2, it is possible to determine the distortion of the electrical signal in the biosignal period Tp, which is a predetermined period. Note that the first period Tp1 and the second period Tp2 can be set as appropriate during the manufacturing or before use of the muscle relaxation monitoring device 1.

[0051] During the setting of the stimulation current value in surgical preparation, the stimulation current is applied multiple times with the current value gradually increased. In this case, it is determined whether the electromyogram for the stimulation current with the maximum value is a second abnormal waveform A2.

[0052] The signal detection unit 14 determines that the output is the second abnormal waveform A2, and the control unit 11 determines that the cause of the installation abnormality is either that the stimulating electrode 41 and the output electrode 51 are too close together, or that the grounding electrode 61 has detached. The result of the installation abnormality is then output from the display output unit 15 and displayed on the display device 2. The display device 2 displays "The stimulating electrode and the output electrode are too close together, or the grounding electrode has detached." When this is displayed, the audio output unit 16 outputs an audio signal and the speaker 3 emits a "beep" sound to warn the user.

[0053] Furthermore, the display when a diagnosis is made may also be a display that informs the user of the appropriate action to take depending on the cause of the installation abnormality. In this case, for example, the display may say, "Please ensure that the grounding electrode is securely attached. If the abnormality persists, please move the attachment positions of the stimulating electrode and the lead electrode further apart."

[0054] (Third abnormal waveform A3) Figure 7 shows the electrical signal of the third abnormal waveform A3 detected by the signal detection unit 14 after nerve stimulation by the stimulation output unit 13, with a solid line. The dotted line is the non-administered waveform E of the electromyogram of a living organism that has not been administered a muscle relaxant, as shown in Figure 2. The first abnormal waveform A1 and the second abnormal waveform A2 show traces of positive peak potential PPe and negative peak potential NPe due to the biological signal, but the third abnormal waveform A3 does not show these traces.

[0055] The third abnormal waveform A3 appears when the lead electrode 51 is detached. When the lead electrode 51 is detached, the waveform may resemble the third abnormal waveform A3, but it may also be a waveform of a different shape. However, when the lead electrode 51 is detached, regardless of the waveform, it is difficult for the potential to converge to 0 mV after the biosignal period Tp. The non-administered waveform E, shown by the dotted line in Figure 7, converges to a potential of 0 mV during the biosignal period Tp. On the other hand, the third abnormal waveform A3, shown by the solid line, has a potential of approximately 5 mV 30 msec from the end of the stimulating current, which is after the biosignal period Tp.

[0056] As shown in Figure 6, the convergence to a potential of 0mV is slow in the second abnormal waveform A2, similar to the third abnormal waveform A3. Therefore, in the muscle relaxation monitoring device 1 of this embodiment, if the absolute value of the voltage at the determination time T, 30 msec after the end of the stimulation current, which is after the biosignal period Tp, is 2mV or more (a predetermined value), and it is not determined to be the second abnormal waveform A2, then it is determined to be the third abnormal waveform A3. The determination time T can be set as appropriate during the manufacturing or before use of the muscle relaxation monitoring device 1. In this way, if the absolute value of the potential after the period in which a biosignal is generated following nerve stimulation by the stimulation output unit 13 is 100% or more, it is determined to be an abnormal detachment of the lead electrode 51.

[0057] During the setting of the stimulation current value in surgical preparation, the stimulation current is applied multiple times with the current value gradually increased. In this case, it is determined whether the electromyogram for the stimulation current with the maximum value is a third abnormal waveform A3.

[0058] The signal detection unit 14 determines that the output is the third abnormal waveform A3, and the control unit 11 determines that the detachment of the lead electrode 51 is the cause of the installation abnormality. The result of the installation abnormality is then output from the display output unit 15 and displayed on the display device 2. The display device 2 displays "Detachment of lead electrode is abnormal." When the display is shown, the audio output unit 16 outputs an audio signal and the speaker 3 emits a "beep" warning sound to alert the user.

[0059] Furthermore, the display when a diagnosis is made may be a message that informs the appropriate action to take depending on the cause of the installation abnormality. In this case, for example, it might display, "Please ensure the lead electrodes are securely attached."

[0060] <Flowchart for determining the cause of installation abnormalities> Figure 8 shows the flowchart for determining and displaying the cause of an installation abnormality. Each step in the flowchart represents the muscle relaxation monitoring method. This procedure is controlled by the control unit 11 processing a muscle relaxation monitoring program stored in the memory unit 12. This muscle relaxation monitoring program can also be recorded on a computer-readable recording medium.

[0061] In this embodiment, the cause of the installation abnormality is determined when the stimulation current value setting unit sets the current value of the stimulation current. At the start, the A1 to A4 flags, which will be described later, are set to 0. When the stimulation current value setting switch (not shown) is turned on using the operation unit 17 shown in Figure 1, a stimulation current value setting start signal is sent to the control unit 11. The control unit 11 sends a stimulation application signal to the stimulation output unit 13 and sets the current value of the stimulation current by repeatedly sending pulses of stimulation current with gradually increasing current values ​​(step S1).

[0062] As shown in Figure 2, if an electromyogram is obtained with a positive peak potential PPe and a negative peak potential NPe within the expected voltage range during the expected biosignal period Tp, the stimulation current value setting is successful. The success of the stimulation current value setting is determined (step S2), and if it is YES, the stimulation current value at that time is stored, and the process proceeds to step S10 to indicate the completion of the stimulation current value setting. The current value when the stimulation current value setting is successful is stored as the current setting value and used as the stimulation current value for the TOF method.

[0063] On the other hand, as the current value of the stimulating current is gradually increased, if an electromyogram is not obtained at the maximum current value, as shown in Figure 2, where a positive peak potential PPe and a negative peak potential NPe are obtained within the expected voltage range during the expected biosignal period Tp, and step S2 is NO, then the electromyogram for the stimulating current with the maximum current value is stored.

[0064] Next, it is determined whether the stored electromyogram is the first abnormal waveform A1 shown in Figure 5 (step S3). If the amplitude fa1, which is the difference between the positive peak potential PPa1 and the negative peak potential NPa1 during the biosignal period Tp of the electromyogram, is greater than or equal to the first reference value SV11 (0.2mV) and less than or equal to the second reference value SV12 (1.0mV), it is determined to be the first abnormal waveform A1. If it is determined to be the first abnormal waveform A1 (YES), the A1 flag is set to 1 (step S4). An A1 flag of 1 means either insufficient nerve stimulation or abnormal proximity of the two lead electrodes 51. After nerve stimulation by the stimulation output unit 13, if the difference between the highest and lowest potentials during the period when a biosignal is generated is within a predetermined voltage range smaller than that of a normal electromyogram, it is determined to be either insufficient nerve stimulation or abnormal proximity of the two lead electrodes 51. In this way, it is determined whether there is insufficient nerve stimulation or abnormal proximity of the two lead electrodes 51.

[0065] If it is determined in step S3 that the electromyogram is not the first abnormal waveform A1 (NO), then it is determined in step S5 whether the stored electromyogram is the second abnormal waveform A2 shown in Figure 6. The electromyogram is determined to be the second abnormal waveform A2 if the absolute value of the average voltage in the first period Tp1 (1-2 msec from the end of the stimulation current) is 20 mV or more, and the absolute value of the average voltage in the second period Tp2 (5-10 msec) is 10 mV or less. If it is determined to be the second abnormal waveform A2 (YES), the A2 flag is set to 1 (step S6). An A2 flag of 1 means either the stimulation electrode 41 and the output electrode 51 are too close together, or the ground electrode 61 is detached. In this way, the determination of whether the stimulation electrode 41 and the output electrode 51 are too close together, or the ground electrode 61 is detached, is made.

[0066] If it is determined in step S5 that the electromyogram is not the second abnormal waveform A2 (NO), then it is determined whether the stored electromyogram is the third abnormal waveform A3 shown in Figure 7 (step S7). If the electromyogram is determined to have a voltage of 2mV or more at the determination time T, 30msec after the end of the stimulation current, then it is determined to be the third abnormal waveform A3. If it is determined to be the third abnormal waveform A3 (YES), the A3 flag is set to 1 (step S6). An A3 flag of 1 indicates an abnormality in the detachment of the lead electrode 51.

[0067] In this flow, step S7, which determines whether or not it is the third abnormal waveform A3, is performed only when it is determined that it is not the second abnormal waveform A2. Therefore, in step S7, it is unnecessary to determine whether or not it is the second abnormal waveform A2. In this way, it is determined whether the stimulation electrode 41 and the output electrode 51 are too close together or whether the ground electrode 61 has detached.

[0068] A flag of 1 for A1-A3 corresponds to determining that the waveform is one of the first abnormal waveforms A1-A3. Determining it as the first abnormal waveform A1 means either insufficient nerve stimulation or an abnormal proximity of the two lead electrodes 51. Determining it as the second abnormal waveform A2 means either the stimulation electrode 41 and the lead electrode 51 are too close together or the ground electrode 61 is detached. Determining it as the third abnormal waveform A3 means the lead electrode 51 is detached. If it is determined in step S7 that it is not the third abnormal waveform A3 (NO), then the A4 flag is set to 1 (step S9). A flag of 1 for A4 means any other abnormality.

[0069] Then, after steps S4, S6, S8, and S9, a warning sound is generated and the judgment result is displayed based on the A1-A4 flags (step S10). If any of the A1-A4 flags are 1, the control unit 11 outputs sound from the audio output unit 16 and generates a "beep" warning sound from the speaker 3. If all of the A1-A4 flags are 0, a "beep" sound is generated. The control unit 11 also outputs a display from the display output unit 15 and displays the judgment result on the display device 2.

[0070] If any of the A1-A4 flags are set to 1, the cause of the installation error corresponding to each flag will be displayed. If the A1 flag is 1, the message "Insufficient nerve stimulation or abnormal proximity of the attachment position of the lead electrode" will be displayed. If the A2 flag is 1, the message "The stimulation electrode and lead electrode are too close together or the ground electrode is detached" will be displayed. If the A3 flag is 1, the message "The lead electrode is detached" will be displayed. If the A4 flag is 1, the message "Installation error" will be displayed. If all of the A1-A4 flags are 0, the message "Current value setting for stimulation current is complete" will be displayed.

[0071] When an installation error is detected, the electrodes are reattached, and then the stimulation current value setting switch is pressed again. Following the flow shown in Figure 8, the stimulation current value is set again, and the cause of the installation error is displayed. This flow is repeated until the stimulation current value setting is successful and the process is completed.

[0072] The above procedure primarily involves detecting abnormalities when setting the current value of the stimulating current during surgical preparation. However, similar abnormality detection may also be performed when monitoring the muscle relaxation state using the TOF method after the current value setting of the stimulating current has been completed. In this case, however, the determination should be made using the electromyogram (EMG) corresponding to the current value of the stimulating current obtained by the TOF method. However, in abnormality detection during surgery, the determination of whether it is the first abnormal waveform A1 in step S3 is not performed. This is because when muscle relaxants are in effect, the waveform may be similar to the first abnormal waveform A1.

[0073] Furthermore, there is little need to determine whether or not the first abnormal waveform A1 is present during surgery. Since the current value setting for the stimulation current has already been completed, the cause of the placement abnormality has already been determined, making it unlikely that the two lead electrodes 51 will be too close together. It is also unlikely that the position of the stimulation electrode 41 will shift, resulting in insufficient nerve stimulation. If the stimulation electrode 41 detaches, it can be detected by monitoring the stimulation current.

[0074] The notification of the cause of the installation abnormality and the notification of the corrective action may be displayed together, or either one may be displayed. Furthermore, the notification of the cause of the installation abnormality and the notification of the corrective action may be provided by voice from speaker 3. The display notification of the cause of the installation abnormality and the notification of the corrective action by display device 2 and the voice notification of the corrective action by speaker 3 may both be used, or either one may be used. In these cases, the display output unit 15 and the voice output unit 16 function as notification output units for notifying the cause of the installation abnormality and the corresponding corrective action. Alternatively, the notification output units may include lighting up a light-emitting element or other device separately provided in the muscle relaxation monitoring device 1, or vibrating a vibration device provided in the muscle relaxation monitoring device 1.

[0075] In this embodiment, the muscle relaxation monitoring device 1 has a display device 2 and a speaker 3 as separate components. However, these may be integrated into a single medical device. Alternatively, the muscle relaxation monitoring device 1 may be incorporated into a medical device system together with other medical devices, and the information from the muscle relaxation monitoring device 1 may be communicated using the display device or speaker of the other medical devices.

[0076] The embodiments primarily described the use of the device before administering muscle relaxants during surgical preparation. However, it can also be used when any of the first abnormal waveform A1 to the third abnormal waveform A3 occurs during surgery, for example, when the effect of the muscle relaxant wears off.

[0077] In this embodiment, the stimulating electrode 41 and the output electrode 51 are connected to the muscle relaxation monitoring device 1 via wiring 42 and signal lines. However, the stimulating electrode 41 may be connected to a stimulator, and the stimulator and the muscle relaxation monitoring device may be connected wirelessly. Alternatively, the output electrode 51 may be connected to a signal detection device, and the signal detection device and the muscle relaxation monitoring device may be connected wirelessly. Wireless connection reduces the amount of wiring required during surgery.

[0078] Furthermore, the specific configuration is not limited to the embodiments, and any design changes, etc., that do not depart from the spirit of the present invention are also included. In addition, the above-mentioned modifications can be combined by utilizing each other's technologies, as long as there are no particular contradictions or problems in their purpose and configuration. [Explanation of symbols]

[0079] L upper limb E Non-administered waveform Positive peak potential of PPe non-administered waveform E NPe Negative peak potential of non-administered waveform E fe Amplitude of non-administered waveform E W1-W4: Four electromyography waveforms of the TOF method f1~f4 Amplitude of four electromyographic waveforms in the TOF method A1 1st abnormal waveform A2 2nd abnormal waveform A3 3rd abnormal waveform PPa1 Positive peak potential of the first abnormal waveform A1 NPa1 Negative Peak Potential of First Abnormal Waveform A1 fa1 Amplitude of the first abnormal waveform A1 Tp1 Period 1 Tp2, Period 2 Tp biosignal period T Judgment point 1. Muscle relaxation monitoring device 11 Control Unit 12 Storage section 13. Stimulation output section 14 Signal detection unit 15 Display Output Section 16 Audio output section 17 Control section 2 Display device 3 speakers 41 Stimulating electrode 42 Wiring 51 Lead-out electrode 52 signal line 61 Ground electrode 62 Ground wire

Claims

1. A stimulation output unit that stimulates nerves via a stimulating electrode, A signal detection unit detects, via an output electrode, the biological signals generated from the muscle in response to nerve stimulation by the aforementioned stimulation output unit as electrical signals. The system includes a stimulation output unit that stimulates nerves, and a cause determination unit that determines the cause of an abnormal installation of the lead electrode based on the electrical signal detected by the signal detection unit. If, after nerve stimulation by the aforementioned stimulation output unit, the difference between the highest and lowest potentials during the period in which a biological signal is generated is within a predetermined voltage range smaller than that of a normal electromyogram, it is determined that there is insufficient nerve stimulation or that the placement of the two aforementioned lead electrodes is abnormal. A muscle relaxation monitoring device characterized by the following features.

2. A stimulation output unit that stimulates nerves via a stimulating electrode, A signal detection unit detects, via an output electrode, the biological signals generated from the muscle in response to nerve stimulation by the aforementioned stimulation output unit as electrical signals. The system includes a stimulation output unit that stimulates nerves, and a cause determination unit that determines the cause of an abnormal installation of the lead electrode based on the electrical signal detected by the signal detection unit. If the electrical signal is distorted during a predetermined period after nerve stimulation by the stimulation output unit, the cause of the installation abnormality is determined to be either that the stimulating electrode and the output electrode are too close together, or that the grounding electrode has detached. A muscle relaxation monitoring device characterized by the following features.

3. A stimulation output unit that stimulates nerves via a stimulating electrode, A signal detection unit detects, via an output electrode, the biological signals generated from the muscle in response to nerve stimulation by the aforementioned stimulation output unit as electrical signals. The system includes a stimulation output unit that stimulates nerves, and a cause determination unit that determines the cause of an abnormal installation of the lead electrode based on the electrical signal detected by the signal detection unit. If, after nerve stimulation by the aforementioned stimulation output unit, the absolute value of the potential after the period during which a biological signal is generated is greater than or equal to a predetermined value, then it is determined that there is an abnormality in the detachment of the lead electrode. A muscle relaxation monitoring device characterized by the following features.

4. On the computer, A stimulation procedure in which a nerve is stimulated via a stimulating electrode by a stimulating output unit, A muscle relaxation monitoring program for executing a detection procedure in which a signal detection unit detects a biological signal generated from a muscle in response to nerve stimulation by the stimulation output unit as an electrical signal via an output electrode, and a determination procedure in which the nerve is stimulated by the stimulation output unit and the cause of an installation abnormality is determined by the electrical signal detected by the signal detection unit, wherein In the above determination procedure, if the difference between the highest and lowest potentials during the period when a biological signal is generated after nerve stimulation by the stimulation output unit is within a predetermined voltage range that is smaller than that of a normal electromyogram, it is determined that there is insufficient nerve stimulation or that the placement of the two lead electrodes is abnormal. Muscle relaxation monitoring program.

5. A computer, A stimulation procedure in which a nerve is stimulated via a stimulating electrode by a stimulating output unit, A muscle relaxation monitoring program for executing a detection procedure in which a signal detection unit detects a biological signal generated from a muscle in response to nerve stimulation by the stimulation output unit as an electrical signal via an output electrode, and a determination procedure in which the nerve is stimulated by the stimulation output unit and the cause of an installation abnormality is determined by the electrical signal detected by the signal detection unit, wherein In the above determination procedure, if the electrical signal is distorted during a predetermined period after nerve stimulation by the stimulation output unit, the cause of the installation abnormality is determined to be either an abnormality where the stimulating electrode and the output electrode are too close together, or an abnormality where the grounding electrode has detached. Muscle relaxation monitoring program.

6. A computer, A stimulation procedure in which a nerve is stimulated via a stimulating electrode by a stimulating output unit, A muscle relaxation monitoring program for executing a detection procedure in which a signal detection unit detects a biological signal generated from a muscle in response to nerve stimulation by the stimulation output unit as an electrical signal via an output electrode, and a determination procedure in which the nerve is stimulated by the stimulation output unit and the cause of an installation abnormality is determined by the electrical signal detected by the signal detection unit, wherein In the above determination procedure, if the absolute value of the potential after nerve stimulation by the stimulation output unit, and after the period during which a biological signal is generated, is greater than or equal to a predetermined value, it is determined that there is an abnormality in the detachment of the lead electrode. Muscle relaxation monitoring program.

7. On the computer, A stimulation procedure in which a nerve is stimulated via a stimulating electrode by a stimulating output unit, A muscle relaxation monitoring program for executing a detection procedure in which a signal detection unit detects a biological signal generated from a muscle in response to nerve stimulation by the stimulation output unit as an electrical signal via an output electrode, and a determination procedure in which the nerve is stimulated by the stimulation output unit and the cause of an installation abnormality is determined by the electrical signal detected by the signal detection unit, wherein In the above determination procedure, if the difference between the highest and lowest potentials during the period when a biological signal is generated after nerve stimulation by the stimulation output unit is within a predetermined voltage range that is smaller than that of a normal electromyogram, it is determined that there is insufficient nerve stimulation or that the placement of the two lead electrodes is abnormal. A computer-readable recording medium containing a muscle relaxation monitoring program.

8. A computer, A stimulation procedure in which a nerve is stimulated via a stimulating electrode by a stimulating output unit, A muscle relaxation monitoring program for executing a detection procedure in which a signal detection unit detects a biological signal generated from a muscle in response to nerve stimulation by the stimulation output unit as an electrical signal via an output electrode, and a determination procedure in which the nerve is stimulated by the stimulation output unit and the cause of an installation abnormality is determined by the electrical signal detected by the signal detection unit, wherein In the above determination procedure, if the electrical signal is distorted during a predetermined period after nerve stimulation by the stimulation output unit, the cause of the installation abnormality is determined to be either an abnormality where the stimulating electrode and the output electrode are too close together, or an abnormality where the grounding electrode has detached. A computer-readable recording medium containing a muscle relaxation monitoring program.

9. A computer, A stimulation procedure in which a nerve is stimulated via a stimulating electrode by a stimulating output unit, A muscle relaxation monitoring program for executing a detection procedure in which a signal detection unit detects a biological signal generated from a muscle in response to nerve stimulation by the stimulation output unit as an electrical signal via an output electrode, and a determination procedure in which the nerve is stimulated by the stimulation output unit and the cause of an installation abnormality is determined by the electrical signal detected by the signal detection unit, wherein In the above determination procedure, if the absolute value of the potential after nerve stimulation by the stimulation output unit, and after the period during which a biological signal is generated, is greater than or equal to a predetermined value, it is determined that there is an abnormality in the detachment of the lead electrode. A computer-readable recording medium containing a muscle relaxation monitoring program.

Citation Information

Patent Citations

  • Method of displaying muscle relaxation parameters and monitor for displaying muscle relaxation state

    JP2006326050A

  • Anesthesia monitoring system and method for monitoring anesthesia

    JP2015506245A

  • Detection of Skin Electrode Abrasion Using Electrode-Skin Impedance

    JP2016515428A

  • Information transmission device

    JP2020065852A

  • Muscle relaxation monitoring device and medical apparatus system

    JP2021069724A